Section
Venture Capital
Following the money, from seed rounds to IPOs. Analysis of funding trends, investor strategies, and market dynamics.

The Private Credit Investment Wave in 2026: What CRE Sponsors Need to Know
Sponsored by Quantum Growth Consultancy · Nov 12

Allstate Agent vs. Independent: Why Gary Daniels Insurance Agency Offers Dallas the Best of Both
Sponsored by Gary Daniels Insurance Agency · Nov 12

When to Pick One Annuity Provider Over Another for Guaranteed Income
Sponsored by Evergreen Legacy · Nov 11

10 Leading ASIC Hosting Providers for 2026
Sponsored by BitHash · Nov 5

Why I Believe Institutional Algorithms Are the Future: My Vincere Portfolios Experience in 2026
The author shares their positive experience in 2026 with Vincere Portfolios, highlighting how institutional algorithms provided the growth they sought after years of mediocre returns from traditional investments. They emphasize the benefits of regulated, diversified algorithmic trading in the evolving financial landscape.
Sponsored by Vincere Portfolios· Oct 29· 6 min

The CRM Agency’s Custom Dashboards Show What Sales Figures Leave Out
Relying solely on sales figures for business intelligence is like navigating with only one point on a map. For Australian e-commerce and retail operators, true growth requires a deeper understanding of the entire custome…
Sponsored by The CRM Agency· Oct 27· 6 min
Analysis & Trends

Three Legal Domains That Decide Whether International VCs Can Fund Your Startup
Marco Giuliani · Nov 14

Day-30 Retention and NRR: The Two Numbers That Prove Product-Market Fit to Seed Investors
Marco Giuliani · Oct 24

Five Criteria LPs Use to Evaluate a Venture Capital Fund — and the Due Diligence Checklist Behind Them
Marco Giuliani · Oct 22

Pre-seed vs. Seed vs. Series A: How Founders Can Tell Which Round They're Actually Raising
Marco Giuliani · Oct 15
Explainers

Inside Formation Bio's $600 Million Hub-and-Spoke Drug Development Fund
Marco Giuliani · Nov 5

Formation Bio's $600 Million Accelerator Fund: How an AI-Native Pharma Company Is Turning Drug Development Into an Asset Class
Marco Giuliani · Nov 5

Venture DAOs vs. Traditional VC Funds: How Decentralized Investing Actually Works
Marco Giuliani · Oct 30

How DeFi Protocols Make Money: The Three Business Models Behind Lending, Trading, and Yield Aggregation
Marco Giuliani · Oct 25

Deep Tech Due Diligence: Why Software VC Metrics Fail and What to Use Instead
Marco Giuliani · Oct 27

Venture Debt for Startups: A Founder's Decision Framework for Timing, Terms, and Traps
Marco Giuliani · Oct 16

